Ratings by SMBC Nikko Securities
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 4/26/2023 | David Hoang | Alnylam Pharmaceuticals | ALNY | New Coverage | Neutral (N/A) |
220.00 (N/A) |
202.15 (320.66) |
58.62% | Details |
| 4/26/2023 | David Hoang | Arrowhead Pharma | ARWR | New Coverage | Outperform (N/A) |
80.00 (N/A) |
33.58 (59.82) |
78.14% | Details |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 140 more... | |||||||||
